IRIS
CAMPENNI', Alfredo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 19.122
NA - Nord America 14.431
AS - Asia 7.109
SA - Sud America 2.394
Continente sconosciuto - Info sul continente non disponibili 557
AF - Africa 224
OC - Oceania 19
Totale 43.856
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.990
RU - Federazione Russa 7.516
IT - Italia 5.362
SG - Singapore 2.841
BR - Brasile 2.057
CN - Cina 1.993
IE - Irlanda 1.658
SE - Svezia 1.589
HK - Hong Kong 809
DE - Germania 656
FR - Francia 503
VN - Vietnam 414
GB - Regno Unito 355
NL - Olanda 355
FI - Finlandia 354
UA - Ucraina 304
IN - India 296
CA - Canada 191
BD - Bangladesh 141
PL - Polonia 121
AR - Argentina 106
TR - Turchia 86
MX - Messico 79
IQ - Iraq 78
ZA - Sudafrica 76
CZ - Repubblica Ceca 59
PK - Pakistan 55
BE - Belgio 51
EC - Ecuador 51
JP - Giappone 51
AT - Austria 47
CO - Colombia 44
ES - Italia 43
ID - Indonesia 39
UZ - Uzbekistan 37
CL - Cile 35
MA - Marocco 33
VE - Venezuela 33
CI - Costa d'Avorio 31
CR - Costa Rica 29
SA - Arabia Saudita 28
AE - Emirati Arabi Uniti 24
LT - Lituania 24
IR - Iran 23
AZ - Azerbaigian 21
JM - Giamaica 20
PY - Paraguay 20
IL - Israele 19
UY - Uruguay 19
CH - Svizzera 18
KE - Kenya 18
TN - Tunisia 18
HN - Honduras 17
PE - Perù 17
PH - Filippine 16
AU - Australia 15
NI - Nicaragua 15
DZ - Algeria 14
KZ - Kazakistan 14
NP - Nepal 14
EG - Egitto 13
MY - Malesia 12
PA - Panama 12
PR - Porto Rico 12
TT - Trinidad e Tobago 12
PS - Palestinian Territory 11
SV - El Salvador 11
AL - Albania 10
BO - Bolivia 10
DO - Repubblica Dominicana 10
GT - Guatemala 10
JO - Giordania 10
KG - Kirghizistan 10
OM - Oman 10
GP - Guadalupe 9
PT - Portogallo 9
RO - Romania 9
TH - Thailandia 9
BG - Bulgaria 8
LB - Libano 8
NO - Norvegia 8
BY - Bielorussia 7
EE - Estonia 7
HU - Ungheria 7
DK - Danimarca 6
EU - Europa 6
GE - Georgia 6
GR - Grecia 6
LV - Lettonia 6
RS - Serbia 6
XK - ???statistics.table.value.countryCode.XK??? 6
CW - ???statistics.table.value.countryCode.CW??? 5
HR - Croazia 5
QA - Qatar 4
AM - Armenia 3
BH - Bahrain 3
BN - Brunei Darussalam 3
BS - Bahamas 3
KH - Cambogia 3
KR - Corea 3
Totale 43.250
Salva come PNG Salva come JPEG
Città #
Moscow 2.161
Ashburn 2.003
Dublin 1.646
Singapore 1.548
Dallas 1.410
Chandler 1.381
San Jose 904
Nyköping 862
Hong Kong 802
Beijing 729
Jacksonville 668
Council Bluffs 476
Milan 470
Rome 415
The Dalles 391
Messina 312
Los Angeles 280
Princeton 277
Lauterbourg 253
Dearborn 246
Medford 240
Munich 239
New York 231
Cambridge 205
Des Moines 203
Naples 192
Ann Arbor 186
São Paulo 164
Boardman 131
Buffalo 128
Ho Chi Minh City 108
Turin 106
Santa Clara 102
Hyderabad 97
Warsaw 97
Turku 94
Bremen 91
Jinan 91
Bari 87
Lancaster 86
Palermo 85
Catania 84
Pune 84
Bologna 83
Redondo Beach 82
Tianjin 80
Hanoi 79
Wilmington 76
Florence 72
Guangzhou 67
Dong Ket 61
Woodbridge 61
Atlanta 59
Genoa 59
Phoenix 57
Belo Horizonte 56
Rio de Janeiro 55
San Mateo 55
Brooklyn 54
Frankfurt am Main 54
Nanjing 53
Shenyang 53
Orem 52
Brussels 51
Helsinki 51
Houston 50
Denver 49
Brasília 47
Montreal 46
Chicago 45
Johannesburg 44
London 43
Columbus 40
North Bergen 39
Tokyo 37
Zhengzhou 35
Ningbo 34
Seattle 34
Chennai 33
Toronto 33
Porto Alegre 32
Stockholm 32
Tashkent 31
Abidjan 30
Brno 30
Brescia 29
Vienna 29
Nanchang 28
Shenzhen 28
Trieste 28
Curitiba 27
Hebei 27
Newark 27
Changsha 26
Parma 26
Baghdad 25
Cagliari 25
Guarulhos 25
Hangzhou 25
Modena 25
Totale 22.899
Salva come PNG Salva come JPEG
Nome #
LA LOCALIZZAZIONE ISTMICA DEL NODULO TIROIDEO MALIGNO RAPPRESENTA UN FATTORE ADDIZIONALE DI RISCHIO PER METASTASI IN PAZIENTI AFFETTI DA CARCINOMA DIFFERENZIATO DELLA TIROIDE (CDT) A BASSO RISCHIO 4.755
EMIAGENESIA TIROIDEA, MORBO DI BASEDOW-GRAVES E CARCINOMA DIFFERENZIATO DELLA TIROIDE: UN’ASSOCIAZIONE MOLTO RARA. 334
99mTc-Methoxy-Isobutyl-Isonitrile Scintigraphy Is a Useful Tool for Assessing the Risk of Malignancy in Thyroid Nodules with Indeterminate Fine-Needle Cytology 288
131I RADIOIODINE THERAPY (RIT) OF HYPERTYROIDISM DUE TO GRAVES’ DISEASE (GD) OR UNI-MULTINODULAR TOXIC GOITER (NTG): OUR EXPERIENCE 266
Acute liver damage following intravenous glucocorticoid treatment for Graves’ ophthalmopathy 260
131I Radioiodine therapy (RIT) of hyperthyroidism due to Graves' disease (GD) or uni-multinodular toxic goiter (NTG): our experience 256
PRE- AND POSTOPERATIVE CEREBRAL PERFUSION ASSESSMENTS IN CHRONIC SUBDURAL HEMATOMA 250
Abscesualized gliomas:predictive value of 99Tc-Leukoscan 246
Effects of GH replacement therapy on thyroid volume and nodule development in GH deficient adults: a retrospective cohort study 232
HYPERPARATHYROIDISM FROM MEDIASTINAL PARATIROID ADENOMA. CASE REPORT. 218
ACCIDENTAL DISCOVERY OF LUNG METATSTASES FROM DIFFERENTIATED THYROID CANCER BY TC-99M PERTECHNETATE SCAN IN A PATIENT WITH SECONDARY HYPERPARATHYROIDISM 215
A didactic experiment showing the Compton scattering by means of a clinical gamma camera 214
Peptide Receptor Radionuclide Therapy and Somatostatin 'cold' Analogues Therapy in the Treatment of GEP-NET Patients: Our Center’ Experience 213
2 years-survival analysis of patients with non-small cell lung cancer by means of 2deoxy-2-[18F]fluoro-D-glucose positron emission tomography: implications of maximum standardized uptake value (SUVmax) 210
Abnormal 99mTc-MIBI Uptakein left lung mimicking a neoplastic lesion in a young woman with nodular goiter. A rare pitfall of 99mTc-MIBI 210
99mTc-HM-PAO SPECT evaluation of regional cerebral blood flow modifications after paediatric hydrocephalus shunting 209
AN UNUSUAL CASE OF MARINE-LENHART SYNDROME. 209
99mTc-MIBI SPECT in the differential diagnosis of brain metastases 208
Abnormal radioiodine uptake on post-therapy whole body scan and sodium/iodine symporter expression in a dermoid cyst of the ovary: report of a case and review of the literature 206
An analytical model for improving absorbed dose calculation accuracy in non spherical autonomous functioning thyroid nodule 205
Cell proliferation parameters and apoptosis indices in pituitary macroadenomas 204
Association of parathyroid carcinoma and thyroid disorders: A clinical review 202
Association of autonously functioning ("hot") thyroid nodules with Hashimotos' thyroiditis (HT). 198
ABLAZIONE RADIOMETABOLICA DEL RESIDUO TIROIDEO POST-CHIRURGICO DOPO STIMOLO CON TSH UMANO RICOMBINANTE (rhTSH) IN PAZIENTI CON OFTALMOPATIA DI GRAVES (OG) DI GRADO MODERATAMENTE SEVERO E SEVERO: STUDIO PROSPETTICO RANDOMIZZATO IN SINGOLO CIECO 197
99mTc-Methoxy-Isobutil-Isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC) 197
BRAFV600Emutation is associated with increased prevalence of contralateral lymph-node metastases in low and low-to-intermediate risk papillary thyroid cancer 197
99mTc-methoxy-isobutyl-isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC) 196
Central nervous system vasculitis after starting methimazole in a woman with Graves' disease 195
Hyperthyroidism treatment with calculated activity of 131-Radioiodine: our experience 192
Prognostic Validity of Dual Tracer PET/CT in the PRRT Enrollment of GEP-NET Patients 191
ACCUMULO DI TECNEZIO IN METASTASI POLMONARI DA CARCINOMA DIFFERENZIATO TIROIDEO (CDT): UNA RARA EVENIENZA 190
Accidental discovery of lung metastases from differentiated thyroid cancer by 99mTc sodium pertechnetate scan in a patient with secondary hyperparathyroidism 190
Abnormal radioiodine uptake in an abdominal dermoid cyst in a patient affected by differentiated thyroid cancer 190
GASTROINTESTINAL SEQUELAE IN SURVIVORS OF CONGENITAL DIAPHRAGMATIC HERNIA 187
Alemtuzumab-induced thyroid events in multiple sclerosis: a systematic review and meta-analysis 187
Is malignant nodule topography an additional risk factor for metastatic disease in low-risk differentiated thyroid cancer? 187
Early preablation rhTSH-stimulated thyroglobulin predicts outcome of differentiated thyroid cancer (DTC) patients 187
ANALYSIS OF THE FACTORS CONDITIONING THE CLINICAL COURSE OF DIFFERENTIATED THYROID CARCINOMA IN CHILDREN AND YOUNG ADULTS 186
Association of primary hyperparathyroidism (p-hyperPTH) with nodular toxic goiter (NTG) 182
Radiometabolic therapy with 131I for the ablation of the thyroid remnant in patients affected by differentiated thyroid cancer: comparison between four different activities 182
HER2 analysis in sporadic thyroid cancer of follicular cell origin 181
Parathyroid carcinoma presenting as normocalcemic hyperparathyroidism 180
Association of primary hyperparathyoidism (p-hyperPTH) with nodular toxic goiter (NTG): a prospective study at an outpatient osteoporosis service. 179
A model to evaluate S values for beta-gamma emitting radionuclides in cubic voxels 179
A simplified method for kidney dosimetry in Lu-177 therapies based on single SPECT-CT and multiple external probe measurements 179
ACCUMULO DI RADIOIODIO IN MIELOMENINGOCELE SECONDARIO A SPINA BIFIDA OCCULTA: PRIMA EVIDENZA DI CONDIZIONE SIMULANTE UNA METASTASI VERTEBRALE DI CARCINOMA DIFFERENZIATO DELLA TIROIDE 178
Can the position of malignant thyroid nodule be considered as additional risk factor for recurrent and/or metastatic disease in patients affected by low risk differentiated thyroid cancer? 178
Braf V600E and 99m-TC MIBI scintigraphy are usefull diagnostic tools in identifying metastatic differentiated thyroid cancer patients refractory to radioiodine therapy. 177
Oxidative stress as a key feature of autoimmune thyroiditis: an update 177
Combined BRAFV600Eanalysis and99mTc-MIBI scintigraphy can be a useful diagnostic tool in differentiated thyroid cancer patients with incomplete bio-chemical response to first radioiodine therapy (RAIT): a pilot investigation 176
Oxidative Stress and Advanced Glycation End Products in Hashimoto's Thyroiditis 176
Autoimmune comorbidities in Hashimoto's thyroiditis: different patterns of association in adulthood and childhood/adolescence 175
Association of autonomously functioning thyroid nodules (AFTNs) with Hashimoto's thyroiditis (HT) 173
Thyroid remnant ablation in differentiated thyroid cancer: searching for the most effective radioiodine activity and stimulation strategy ina real life scenario 173
Aplotipi del microsatellite D7S6440, localizzato nell'introne 9 del gene HIPK2, come marcatori molecolari della tiroidite di Hashimoto 173
Clinical usefulness of 99mTc-MIBI scintigraphy in the postsurgical evaluation of patients with differentiated thyroid cancer 173
Follicular variant of papillary thyroid carcinoma presenting as toxic nodule in an adolescent: coexistent polymorphism of the TSHR and Gsα genes 172
Coexistence of diffuse large B-cell lymphoma and papillary thyroid carcinoma in a patient affected by hashimoto's thyroiditis 172
Isthmus topography is a risk factor for persistent disease in patients with differentiated thyroid cancer 172
Differentiating malignant from benign thyroid nodules with indeterminate cytology by 99mTc-MIBI scan: A new quantitative method for improving diagnostic accuracy 171
ATYPICAL PRESENTATION OF PARATHYROID CARCINOMA (PC): REPORT OF TWO CASES 169
Abla zione radiometabolica dopo rhTSH del residuo tiroideo post -chirurgico in pazienti con orbitopatia di Graves moderatamente severa e severa 169
Internal Dosimetry of Ellipsoidal Targets: models and applications 168
Meningocele due to closed spina bifida mimicking a metastasis of papillary thyroid carcinoma on whole body radioactive iodine scan 167
Association between primary hyperprathyroidism (p-hyperPTH) and nodular toxic goiter (NTG): a prospective study at an outpatient service for osteoporosis 166
ASSOCIATION OF PRIMARY HYPERPARATHYROIDISM (P-HYPERPTH) WITH NODULAR TOXIC GOITER (NTG): A PROSPECTIVE STUDY AT AN OUTPATIENT OSTEOPOROSIS SERVICE 166
Hyperthyroidism treatment with calculated activity of 131–radioiodine 165
Iodine-131 treatment of hyperthyroidism: our experience 164
An uncommon case of Marine-Lenhart syndrome 164
Evaluation Of Absorbed Doses To Autonomous Thyroid Nodules During 131I Treatment Of Hyperthyroidism: Traditional Approach Versus Monte Carlo Calculation 163
Scintigraphic evaluation of colonic motility in patients with anorectal malformations and constipation 163
FOLLICULAR VARIANT OF PAPILLARY THYROID CARCINOMA PRESENTING AS A TOXIC NODULE IN AN ADOLESCENT GIRL 163
Differentiated thyroid carcinoma in lingual thyroid 163
Association of autonomously functioning thyroid nodules with Hashimoto’s thyroiditis: study on a large series of patients 162
La paratiroidectomia radioguidata 162
Association of primary hyperparathyroidism (p-hyperPTH) with nodular toxic goiter (NTG): a prospective study at an outpatient osteoporosis service 161
Can the position of malignant thyroid nodule be considered as additional risk factor for recurrent and/or metastatic disease in patients affected by low-risk differentiated thyroid cancer? 160
A model for computing absorbed fractions for alpha particles in ellipsoidal volumes 160
Supra-Acetabular Brown Tumor due to Primary Hyperparathyroidism Associated with Chronic Renal Failure 159
Associazione tra noduli tiroidei iperfunzionanti (noduli "caldi") e tiroidite di Hashimoto 158
I livelli sierici del recettore solubile per i prodotti avanzati di glicazione sono ridotti in pazienti pediatrici con tiroidite di Hashimoto 158
Advances in Monte Carlo patient-specific internal dosimetry for 90 Y-TARE treatments. 157
Endocrine and metabolic adverse effects of immune checkpoint inhibitors: an overview (what endocrinologists should know) 157
Comparing radioiodine abdominal absorbed dose in differentiated thyroid cancer patients undergone thyroid remnant ablation in either levo-thyroxine withdrawal or after rhtsh stimulation 157
Hashimoto's thyroiditis is a frequent association of primary hyperparathyroidism, of which it modifies biochemical and bone density indices 156
PRRT retreatments: renal function evaluation 156
BRAFV600E and 99mTc-MIBI scintigraphy are usefull diagnostic tools in identifying metastatic differentiated thyroid cancer patients refractory to radioiodine therapy 155
Association of autonomously functioning ("hot") thyroid nodules with Hashimoto's thyroiditis 154
I carcinomi tiroidei differenziati. 154
Comment on “Prevalence of undifferentiated inflammatory arthropathy in patients with Hashimoto's thyroiditis in an endocrinology clinic” by Luis M. Valderrama-Hinds and co-workers. Int J Rheum Dis 2019; 22: 1985-1989 154
ATYPICAL PRESENTATION OF PARATHYROID CARCINOMA (PC): REPORT OF TWO CASES 153
Is %ΔSUVmax a Useful Indicator of Survival in Patients with Advanced Nonsmall-Cell Lung Cancer? 153
Hepatocyte growth factor/C-met axis in thyroid cancer: From diagnostic biomarker to therapeutic target 153
Effetto proinfiammatorio degli oligosaccaridi dell'acido ialuronico in tireociti e fibroblasti umani: ruolo dei recettori tool-like di tipo 2(TLR-2) e 4(TLR-4) 153
BRAF and RAS mutations in differentiated thyroid cancer of patients with low-risk to intermediate-risk treated with radioiodine therapy 153
An User-Friendly Approach to the Evaluation of Skin and Eye Lens Doses to the Operators in Nuclear Medicine through Dedicated Monte Carlo Simulations in GAMOS 152
Usefulness of L-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: A randomized. double-blind, placebo-controlled clinical trial 151
Importanza del campionamento precoce del TSH, basale e stimolato dal TRH, nell'ipotiroidismo subclinico 151
IODINE-131 TREATMENT OF HYPERTHYROIDISM:OUR EXPERIENCE. 151
Meningocele mimicking a metastasis of papillary thyroid carcinoma 151
Totale 22.906
Salva come PNG Salva come JPEG
Categoria #
all - tutte 138.884
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 138.884
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.625 0 0 0 74 62 23 103 100 32 318 283 630
2022/20235.160 395 526 245 381 402 575 78 303 2.006 40 150 59
2023/20242.469 116 181 145 202 162 425 123 150 99 295 192 379
2024/20258.397 312 217 314 595 497 372 387 1.565 1.634 559 741 1.204
2025/202618.371 1.008 1.202 1.418 1.173 1.461 3.739 2.149 2.244 2.312 906 362 397
2026/20273.190 368 746 853 1.223 0 0 0 0 0 0 0 0
Totale 43.856